G183S (p.Gly183Ser) variant of GLA (Alpha-galactosidase A)

G183S (p.Gly183Ser) in GLA (Alpha-galactosidase A) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as pathogenic/likely pathogenic in the context of Cardiovascular phenotype; not provided; Fabry disease. The available variant effect predictions contribute to a CATVariant prioritization score of 0.77 / 1. The record also includes published literature and structural context.

G183S (p.Gly183Ser) variant details